Jared Wolff and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topics covered in this episode include:
- Tesaro buyout rumors and analysis
- Keytruda's approval in decentralized tumors with MSI-H and DMMR biomarkers
- Cyramza's positive data in bladder cancer - does it stack up against I/O?
To learn more about Datamonitor Healthcare and our offerings, vist:
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: